Guidelines for management of patients with a short bowel

Gut

Volumn 55, Issue SUPPL. 4, 2006, Pages

  Nightingale, J ^a   Woodward, J M ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; CIMETIDINE; DIGOXIN; LOPERAMIDE; MAGNESIUM; OCTREOTIDE; OMEPRAZOLE; RANITIDINE; THYROXINE; WARFARIN;

CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFUSION; DIARRHEA; DRUG ABSORPTION; GALLSTONE; GASTROINTESTINAL MOTILITY; HUMAN; HYPOMAGNESEMIA; INTESTINE ABSORPTION; INTESTINE RESECTION; JEJUNOSTOMY; MALABSORPTION; MALNUTRITION; MINERAL DEFICIENCY; NEPHROLITHIASIS; NUTRITIONAL SUPPORT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; REVIEW; SHORT BOWEL SYNDROME; SOCIAL PROBLEM; SODIUM DEPLETION; VITAMIN DEFICIENCY; XEROSTOMIA;

COLON; ELECTROLYTES; ENTERAL NUTRITION; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; JEJUNOSTOMY; MALNUTRITION; PARENTERAL NUTRITION, TOTAL; QUALITY OF LIFE; SHORT BOWEL SYNDROME;

EID: 33746087091     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.091108     Document Type: Review

References (166)

1. Eccles M, Clapp Z, Grimshaw J, et al. North of England evidence based guidelines project: methods of guideline development. BMJ 1996;312:760-2.
2. Nightingale JMD, Bartram CI, Lennard-Jones JE. Length of residual small bowel after partial resection: Correlation between radiographic and surgical measurements. Gastrointest Radiol 1991;16:305-6.
3. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. J Parenter Enteral Nutr 1996;20:275-80.
4. Nightingale JMD. Introduction. Definition and classification of intestinal failure. In, Nightingale JMD, eds. Intestinal failure Greenwich, Greenwich Medical Media Limited, 2001:xix-xx..
5. Jeppesen PB, Mortensen PB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut. 2000;46:701-6
6. (erratum appears in Gut, 2000;47:158).
7. Nightingale JMD. The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc 2003;62:703-10.
8. Nightingale JMD, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces the need for parenteral therapy, increases the incidence of renal stones but does not change the high prevalence of gallstones in patients with a short bowel. Gut 1992;33:1493-7.
9. Gouttebel MC, Saint-Aubert B, Astre C, et al. Total parenteral nutrition needs in different types of short bowel syndrome. Dig Dis Sci 1986;31:718-23.
10. Simons BE, Jordan GL. Massive bowel resection. Am J Surg 1969;118:953-9.
11. Nightingale JMD, Kamm MA, van der Sijp JRM, et al. Disturbed gastric emptying in the short bowel syndrome. Evidence for a "colonic brake". Gut 1993;34:1171-6.
12. Nightingale JMD, Kamm MA, van der Sijp JRM, et al. Gastrointestinal hormones in the short bowel syndrome. PYY may be the 'colonic brake' to gastric emptying. Gut 1996;39:267-72.
13. Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum-resected short bowel patients with a preserved colon. Gut 2000;47:370-6.
14. Jeppesen PB, Hartmann B, Hansen BS, et al. Impaired stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999;45:559-63.
15. Nightingale JMD, Lennard-Jones JE, Walker ER, et al. Jejunal efflux in short bowel syndrome. Lancet 1990;336:765-8.
16. Newton CR, Drury P, Gonvers JJ, et al. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol 1982;74(suppl):159-60.
17. Windsor CWO, Fejfar J, Woodward DAK. Gastric secretion after massive small bowel resection. Gut 1969;10:779-86.
18. 12 in man. Lancet 1959;i:18-21.
19. Booth CC. The metabolic effects of intestinal resection in man. Postgrad Med J 1961;37:725-39.
20. Booth CC, Alldis D, Read AE. Studies on the site of fat absorption: 2. Fat balances after resection of varying amounts of the small intestine in man. Gut 1961;2:168-74.
21. Hessov I, Andersson H, Isaksson B. Effects of a low-fat diet on mineral absorption in small-bowel disease. Scand J Gastroenterol 1983;18:551-4.
22. Hanna S, MacIntyre I. The influence of aldosterone on magnesium metabolism. Lancet 1960;2:348-50.
23. Horton R, Biglieri EG. Effect of aldosterone on the metabolism of magnesium. J Clin Endocrinol Metab 1962;22:1187-92.
24. Fatemi S, Ryzen E, Flores J, et al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25 dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991;73:1067-72.
25. Zofkova I, Kancheva RL. The relationship between magnesium and calciotropic hormones. Magnes Res 1995;8:77-84.
26. Crenn P, Beloucif L, Morin MC, et al. Adaptive hyperphagia and net digestive absorption in short bowel patients. Gastroenterology 1997;112:A356.
27. Goodlad RA, Nightingale JMD, Playford RJ. Intestinal adaptation. In: Nightingale JMD, eds. Intestinal failure. Greenwich: Greenwich Medical Media Limited, 2001:243-60.
28. Porus RL. Epithelial hyperplasia following massive small bowel resection in man. Gastroenterology 1965;48:753-9.
29. De Francesco A, Malfi G, Delsedime L, et al. Histological findings regarding jejunal mucosa in short bowel syndrome. Transplant Proc 1994;26:1455-6.
30. Althausen TL, Doig RK, Uyeyama K, et al. Digestion and absorption after massive resection of the small intestine. II. Recovery of the absorptive function as shown by intestinal absorption tests in two patients and a consideration of compensatory mechanisms. Gastroenterology 1950;16:126-34.
31. Dowling RH, Booth CC. Functional compensation after small bowel resection in man: Demonstration by direct measurement. Lancet 1966;ii:146-7.
32. Cosnes J, Carbonnel F, Beaugerie L, et al. Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol 1994;6:197-202.
33. Gouttebel MC, Saint Aubert B, Colette C, et al. Intestinal adaptation in patients with short bowel syndrome. Measurement by calcium absorption. Dig Dis Sci 1989;34:709-15.
34. Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043-50.
35. O'Keefe SJD, Haymond MW, Bennet WM, et al. Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology 1994;107:379-88.
36. Hill GL, Mair WSJ, Goligher JC. Impairment of 'ileostomy adaptation' in patients after ileal resection. Gut 1974;15:982-7.
37. Nightingale JMD, Walsh N, Bullock ME, et al. Comparison of three simple methods for the detection of malnutrition. J R Soc Med 1996;89:144-8.
38. Stratton RJ, Hackston A, Longmore D, et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults. Br J Nutr 2004;92:799-808.
39. American Gastroenterological Association medical position statement. Short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1105-10.
40. Nightingale JMD. Gastrostomy placement in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2000;12:1073-5.
41. Rodrigues CA, Lennard-Jones, Thompson DG, et al. Energy absorption as a measure of intestinal failure in the short bowel syndrome. Gut 1989;30:176-83.
42. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986;91:100-7.
43. Ammon HV, Phillips SF. Inhibition of colonic water and electrolyte absorption by fatty acids in man. Gastroenterology 1973;65:744-9.
44. Knapp HR, Melly MA. Bactericidal effects of polyunsaturated fatty acids. J Infect Dis 1986;154:84-94.
45. Andersson H. The use of a low-fat diet in the symptomatic treatment of ileopathia. World Rev Nutr Diet 1982;40:1-18.
46. Ovesen L, Chu R, Howard L. The influence of dietary fat on jejunostomy output in patients with severe short bowel syndrome. Am J Clin Nutr 1983;38:270-7.
47. Jeppesen PB, Christensen MS, Hoy CE, et al. Essential fatty acid deficiency in patients with severe fat malabsorption. Am J Clin Nutr 1997;65:837-43.
48. Press M, Hartop PJ, Prottey C. Correction of essential fatty-acid deficiency in man by cutaneous application of sunflower-seed oil. Lancet 1974;ii:597-9.
49. Zurier RB, Campbell RG, Hashim SA, et al. Use of medium-chain triglyceride in management of patients with massive resection of the small intestine. N Engl J Med 1966;274:490-3.
50. Bochenek W, Rodgers JB Jr, Balint JA. Effects of changes in dietary lipids on intestinal fluid loss in the short-bowel syndrome. Ann Intern Med 1970;72:205-13.
51. Tandon RK, Rodgers JB Jr, Balint JA. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Am J Dig Dis 1972;17:233-8.
52. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.
53. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet 1994;343:373-6.
54. Gruy-Kapral C, Little KH, Fortran JS, et al. Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology 1999;116:15-21.
55. Heydorn S, Jeppesen PB, Mortensen PB. Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastroenterol 1999;34:818-23.
56. Ladefoged K, Ølgaard K. Fluid and electrolyte absorption and renin-angiotensin-aldosterone axis in patients with severe short-bowel syndrome. Scand J Gastroenterol 1979;14:729-35.
57. Ladefoged K, Ølgaard K. Sodium homeostasis after small-bowel resection. Scand J Gastroenterol 1985;20:361-9.
58. Davis AT, Franz FP, Courtnay DA, et al. Plasma and mineral status in home parenteral nutrition patients. J Parenter Enteral Nutr 1987;11:480-5.
59. Shenkin A, Fell GS, Halls DJ, et al. Essential trace element provision to patients receiving home intravenous nutrition in the United Kingdom. Clin Nutr 1986;5:91-7.
60. Rannem T, Ladefoged K, Hylander E, et al. Selenium depletion in patients on home parenteral nutrition. The effect of selenium supplementation. Biol Trace Element Res 1993;39:81-90.
61. 75Se] selenite in patients with short bowel syndrome. J Parenter Enteral Nutr 1996;20:412-16.
62. Wolman SL, Anderspon GH, Marliss EB, et al. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology 1979;76:458-67.
63. Hofmann AF, Poley JR. Role of bile acid malabsorption in the pathogenesis of diarrhoea and steatorrhoea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglycerides. Gastroenterology 1972;62:918-34.
64. Editorial. The colon, the rumen, and D-lactic acidosis. Lancet 1990;336:599-600.
65. Mayne AJ, Handy DJ, Preece MA, et al. Dietary management of D-lactic acidosis in short bowel syndrome. Arch Dis Child 1990;65:229-31.
66. Yamada E, Wakabayashi Y, Saito A, et al. Hyperammonaemia caused by essential aminoacid supplements in patient with short bowel. Lancet 1993;341:1542-3.
67. Yokoyama K, Ogura Y, Kawabata M, et al. Hyperammonemia in a patient with short bowel syndrome and chronic renal failure. Nephron 1996;72:693-5.
68. Brophy DF, Ford SL, Crouch MA. Warfarin resistance in a patient with short bowel syndrome. Pharmacotherapy 1998;18:646-9.
69. Ehrenpreis ED, Guerriero S, Nogueras JJ, et al. Malobsorption of digoxin tablets, gel caps, and elixir in a patient with an end jejunostomy. Ann Pharmacotherap 1994;28:1239-40.
70. Nealon WH, Upp JR, Alexander RW, et al. Intravenous amino acids stimulate human gallbladder emptying and hormone release. Am J Physiol 1990;259:G173-8.
71. Doty JE, Pitt HA, Porter-Fink V, et al. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg 1985;201:76-80.
72. Lee SP, Carey MC, LaMont JT. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981;211:1429-31.
73. O'Donnell LJD, Wilson P, Guest P, et al. Indomethacin and post-prandial gallbladder emptying. Lancet 1992;339:269-71.
74. Williams C, Gowan R, Perey BJ. A double-blind placebo-controlled trial of ursodeoxycholic acid in the prevention of gallstones during weight loss after vertical banded gastroplasty. Obes Surg 1993;3:257-9.
75. Hussaini SH, Pereira SP, Dowling RH, et al. Slow intestinal transit and gallstone formation. Lancet 1993;341:638.
76. Capron J-P, Gineston J-L, Herve M-A, et al. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet 1983;i:446-7.
77. Thompson JS. The role of prophylactic cholecystetomy in the short bowel syndrome. Arch Surg 1996;131:556-60.
78. Chadwick VS, Modha K, Dowling RH. Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 1973;289:172-6.
79. Stauffer JQ, Humphreys MH, Weir GJ. Acquired hyperoxaluria with regional enteritis after ileal resection. Role of dietary oxalate. Ann Intern Med 1973;79:383-91.
80. Earnest DL, Johnson G, Williams HE, et al. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology 1974;66:1114-22.
81. Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977;296:298-301.
82. Tomson CRV. Nephrocalcinosis and nephrolithiasis. In: Nightingale JMD, eds. Intestinal failure. Greenwich: Greenwich Medical Media Limited, 2001:227-42.
83. Rudman D, Dedonis JL, Fountain MT, et al. Hypocitraturia in patients with gastrointestinal malabsorption. N Engl J Med 1980;303:657-61.
84. AGA Technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1111-34.
85. Earnest DL, Williams HE, Admirand WH. A physicochemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Physicians 1975;88:224-34.
86. Caspary WF, Tonissen J, Lankisch PG. Enteral hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man. Acta Hepatogastroenterol (Stuttg) 1977;24:193-200.
87. Barilla DE, Notz C, Kennedy D, et al. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium. Am J Med 1978;64:579-85.
88. Lindsjo M, Fellstrom B, Ljunghall S, et al. Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 1989;ii:701-4.
89. Smith LH, Fromm H, Hofmann AF. Acquired hyperoxaluria, nephrocalcinosis, and intestinal disease. Description of a syndrome. N Engl J Med 1972;286:1371-5.
90. Whang R, Whang DD, Ryan MP. Refactory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992;152:40-5.
91. + homeostasis. Semin Nephrol 1987;7:253-62.
92. Newton CR, Drury P, Gonvers JJ, et al. Incidence and treatment of sodium depletion in ileostomists. Scand J Gastroenterol 1982;74(suppl):159-60.
93. Griffin GE, Fagan EF, Hodgson HJ, et al. Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci 1982;27:902-8.
94. Kennedy HJ, Al-Dujaili EAS, Edwards CRW, et al. Water and electrolyte balance in subjects with a permanent ileostomy. Gut 1983;24:702-5.
95. Newton CR, Gonvers JJ, McIntyre PB, et al. Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med 1985;78:27-34.
96. Rodriguez CA, Lennard-Jones JE, Thompson DG, et al. What is the ideal sodium concentration of oral rehydration solutions for short bowel patients? Clin Sci 1988;74(suppl 18):69.
97. Nightingale JMD, Lennard-Jones JE, Walker ER, et al. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution and glucose polymer electrolyte solution (Maxijul). Gut 1992;33:759-61.
98. Woolf GM, Miller C, Kurian R, et al. Nutritional absorption in short bowel syndrome. Evaluation of fluid, calorie and divalent cation requirements. Dig Dis Sci 1987;32:8-15.
99. Olsen WA, Ingelfinger FJ. The role of sodium in intestinal glucose absorption in man. J Clin Invest 1968;47:1133-42.
100. Sladen GE, Dawson AM. Interrelationships between the absorptions of glucose, sodium and water by the normal human jejunum. Clin Sci 1969;36:119-32.
101. Fordtran JS. Stimulation of active and passive sodium absorption by sugars in the human jejunum. J Clin Invest 1975;55:728-37.
102. Avery ME, Snyder JD. Oral therapy for acute diarrhoea. The underused simple solution. N Engl J Med 1990;323:891-94.
103. Newton CR. Effect of codeine phosphate, Lomotil and Isogel on ileostomy function. Gut 1978;19:377-83.
104. King RFGJ, Norton T, Hill GL. A double-blind crossover study of the effect of loperamide hydrochloride and codeine phosphate on ileostomy output. Aust NZ J Surg 1982;52:121-4.
105. Tytgat GN, Huibregtse K. Loperamide and ileostomy output-placebo- controlled double-blind crossover study. BMJ 1975;2:667-8.
106. Tytgat GN, Huibregtse K, Dagevos J, et al. Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis. Dig Dis 1977;22:669-76.
107. Nightingale JMD, Lennard-Jones JE, Walker ER. A patient with jejunostomy liberated from home intravenous therapy after 14 years; contribution of balance studies. Clin Nutr 1992;11:101-5.
108. 2-receptor blocking agent on diarrhoeas after extensive small bowel resection in Crohn's disease. Acta Med Scand 1980;207:119-22.
109. Jacobsen O, Ladefoged K, Stage JG, et al. Effects of cimetidine on jejunostomy effluents in patients with severe short bowel syndrome. Scand J Gastroenterol 1986;21:824-8.
110. Nightingale JMD, Walker ER, Farthing MJG, et al. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Therap 1991;5:405-12.
111. Jeppesen PB, Staun M, Tjellesen L, et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, macronutrients in patients with intestinal resection. Gut 1998;43:763-9.
112. Rodrigues CA, Lennard-Jones JE, Walker ER, et al. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short bowel syndrome. Aliment Pharmacol Ther 1989;3:159-69.
113. Cooper JC, Williams NS, King RFGJ, et al. Effects of a long acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg 1986;73:128-31.
114. Kusuhara K, Kusunoki M, Okamoto T, et al. Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995. Int J Colorect Dis 1992;7:202-5.
115. Shaffer JL, O'Hanrahan T, Rowntree S, et al. Does somatostatin analogue (201-995) reduce high output stoma effluent? A controlled trial. Gut 1988;29:A1432-3.
116. Nightingale JMD, Walker ER, Burnham WR, et al. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Therap 1989;3:367-73.
117. Nightingale JMD. The Sir David Cuthbertson Medal Lecture. Clinical problems of a short bowel and their treatment. Proc Nutr Soc 1994;53:373-91.
118. Ladefoged K, Christensen KC, Hegnhoj J, et al. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 1989;30:943-9.
119. Lémann M, de Montigny S, Mahé S, et al. Effect of octreotide on water and electrolytes losses, nutrient absorption and transit in short bowel syndrome. Eur J Gastroenterol Hepatol 1993;5:817-22.
120. O'Keefe SJD, Peterson ME, Fleming R. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. J Parenter Enteral Nutr 1994;18:26-34.
121. Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001;96:1494-8.
122. Goulston K, Harrison DD, Skyring AP. Effect of mineralocorticoids on the sodium/potassium ratio of human ileostomy fluid. Lancet 1963;ii:541-3.
123. Levitan R, Goulston K. Water and electrolyte content of human ileostomy fluid after d-aldosterone administration. Gastroenterology 1967;52:510-12.
124. Kramer P, Levitan R. Effect of 9 α-fludrocortisone on the ileal excreta of ileostomized subjects. Gastroenterology 1972;62:235-41.
125. Feretis CB, Vyssoulis GP, Pararas BN, et al. The influence of corticosteroids on ileostomy discharge of patients operated for ulcerative colitis. Am Surg 1984;50:433-6.
126. Martinez-Riquelme A, Rawlings J, Morley S, et al. Self-administered subcutaneous fluid infusion at home in the management of fluid depletion and hypomagnesaemia in gastro-intestinal disease. Clin Nutr 2005;24:158-63.
127. Selby PL, Peacock M, Bambach CP. Hypomagnesaemia after small bowel resection: treatment with 1 alpha-hydroxylated vitamin D metabolites. Br J Surg 1984;71:334-7.
128. 3 treatment. J Clin Endocrinol Metab 1987;65:1301-4.
129. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a jejunostomy do not need a special diet. Gastroenterology 1986;91:25-33.
130. Woolf GM, Miller C, Kurian R, et al. Diet for patients with a short bowel: high fat or high carbohydrate? Gastroenterology 1983;84:823-8.
131. Ellegard L, Bosaeus I, Nordgren S, et al. Low-dose recombinant growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997;225:88-96.
132. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology, 1997;113;1074-81.
133. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000;47:199-205.
134. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003;124:293-302.
135. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology 2001;120:806-15.
136. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005;54:1224-31.
137. Shanbhogue LKR, Molenaar JC. Short bowel syndrome: metabolic and surgical management. Br J Surg 1994;81:486-99.
138. Thompson JS. Surgery for patients with a short bowel. In: Nightingale JMD, eds. Intestinal failure. Greenwich: Greenwich Medical Media Limited, 2001:515-27.
139. Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986;200:383-6.
140. Stokes MA, Irving M. Mortality in patients on home parenteral nutrition. J Parenter Enteral Nutr 1989;13:172-5.
141. Messing B, Landais P, Goldfarb B, et al. Home parenteral nutrition in adults: a multicentre survey in Europe. Clin Nutr 1989;8:3-9.
142. Messing B, Lèman M, Landais P, et al. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition. Gastroenterology 1995;108:1005-10.
143. Van Gossum A. ESPEN-HAN group. Home parenteral nutrition (HPN) in adults: a multicentre survey in Europe in 1993. Clin Nutr 1996;15:53-8.
144. Scolapio SJ, Fleming CR, Kelly DG, et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clinic Proc 1999;74:217-22.
145. Van Gossum A, Bakker H, Bozzetti F, et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. Clin Nutr 1999;18:135-40.
146. Pironi L, Paganelli P, Morselli LAM, et al. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16 year experience at a single centre. Dig Liver Dis 2003;35:314-24.
147. Woodward JM, Mayer AD. The unique challenge of small intestinal transplantation. Br J Hosp Med 1996;56:285-90.
148. Intestinal transplant registry. http://www. intestinaltransplantregistry@uhn.on.ca.
149. Cameron EA, Binnie JA, Jamieson NV, et al. Quality of life in adults following small bowel transplantation. Transplantation Proc 2002;34:965-6.
150. Messing B, Crenn P, Beau P, et al. Long term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043-50.
151. Jeppesen PB, Staun M, Mortensen PB. Adult patients receiving home parenteral nutrition in Denmark from 1991-1996: who will benefit from intestinal transplantation? Scand J Gastroenterol 1998;338:839-46.
152. Bozzetti F, Mariani L, Boggio BD, et al. EPSEN-HAN working group. Central venous catheter complications in 447 patients on home paraenteral nutrition: an analysis of over 100000 catheter days, Clin Nutr 2002;21:475-85.
153. Hayden L, Stewart GR, Johnson DC, et al. Transthoracic right atrial cannulation for total parenteral nutrition. Anaesth Intensive Care 1981;9:53-7.
154. Lammermeier D, Steiger E, Cosgrove D. Use of an intercostal vein for central vascular access in home parenteral nutrition: a case report. J Parenter Enteral Nutr 1986;10:659-61.
155. Buchman AL, Misra SS, Moukarzel A, et al. Catheter thrombosis and superior/inferior vena cava syndrome are rare complications of long term parenteral nutrition. Clin Nutr 1994;13:356-60.
156. Turner SM, Probert CSJ, Lear P. Parenteral nutrition via an arteriovenous bypass graft. Gut 2003;52:1218.
157. Clarke PJ, Ball MJ, Kettelwell MG. Liver function tests in patients receiving parenteral nutrition. J Parenter Enteral Nutr 1991;15:54-9.
158. Ito Y, Shils ME. Liver dysfunction associated with long term total parenteral nutrition in patients with massive bowel resection. J Parenter Enteral Nutr 1991;15:271-6.
159. Quigley EMM, Marsh MN, Schaffer JL, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
160. Nightingale JMD. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 2003;17:907-29.
161. O'Keefe SJD, Burnes JU, Thompson RL. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. J Parenter Enteral Nutr 1994;18:256-63.
162. Richards DM, Scott NA, Shaffer J, et al. Opiate and sedative dependence predicts a poor outcome for patients receiving home parenteral nutrition. J Parenter Enteral Nutr 1997;21:336-8.
163. Luman W, Schaffer J. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 2002;21:337-43.
164. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000;132:525-32.
165. Middleton SJ, Pollard S, Friend PJ, et al. Adult small intestinal transplantation in England and Wales. Br J Surg 2003;90:723-7.
166. Middleton SJ, Jamieson NV. The current status of small bowel transplantation in the UK and Internationally. Gut 2005;54:1650-7.